The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

However, it "seeks fair compensation for Pfizer's use of a coronavirus 3CL protease inhibitor claimed in the '953 patent." There's a potential third wheel in the dispute, according to SVB ...

targeting the Mpro (3CL protease), without the need for co-administration of ritonavir. Some of the statements in this release are forward-looking statements within the meaning of Section 27A of ...

The group selected nine major phytochemicals present in the plant and simulated docking with 3CL pro of both SARS-CoV-2 and MERS-CoV, finding that three had favorable docking energies and could ...